Published in J Neurooncol on October 01, 1997
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer | NCT02549534
Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol (2011) 2.61
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain (2006) 2.51
Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol (2010) 1.71
Persistent mobility disability after neurotoxic chemotherapy. Phys Ther (2010) 1.55
Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain (2010) 1.51
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res (2008) 1.45
Burden of chemotherapy-induced neuropathy--a cross-sectional study. Support Care Cancer (2010) 1.13
Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience (2011) 1.10
Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One (2011) 1.08
Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients. J Pain (2011) 1.06
Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel. Eur J Neurosci (2011) 1.00
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol (2015) 0.94
Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res (2012) 0.85
Effect of ethyl pyruvate on Paclitaxel-induced neuropathic pain in rats. Korean J Pain (2013) 0.82
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy. J Pain (2015) 0.82
Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A. Pain (2013) 0.82
Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy. Neuroscience (2016) 0.81
Pain in cancer survivors. Br J Pain (2014) 0.81
Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel. Neurotoxicology (2010) 0.78
Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction. Brain Behav (2015) 0.78
Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer (2016) 0.77
Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms. PLoS One (2013) 0.77
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front Mol Neurosci (2017) 0.76
Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Exp Neurol (2016) 0.75
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. Br J Cancer (2005) 0.75
Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy. Sci Rep (2017) 0.75
Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice. PLoS One (2017) 0.75
Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med (1999) 9.43
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med (1996) 4.91
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet (2001) 4.48
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
The syntaxin family of vesicular transport receptors. Cell (1993) 4.14
Reducing workload in systematic review preparation using automated citation classification. J Am Med Inform Assoc (2005) 3.79
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989. Int J Epidemiol (1990) 3.50
Safe, live Vibrio cholerae vaccines? Vaccine (1988) 2.74
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. J Clin Oncol (1998) 2.52
Treatment for primary CNS lymphoma: the next step. J Clin Oncol (2000) 2.47
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology (2000) 2.09
Long-term survival in primary CNS lymphoma. J Clin Oncol (1998) 1.87
SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science (1992) 1.83
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions. Neurosurgery (2000) 1.83
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology (1996) 1.74
Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology (2000) 1.72
Microinjection of intact 200- to 500-kb fragments of YAC DNA into mammalian cells. Genomics (1993) 1.71
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol (1995) 1.71
Stroke in patients with cancer: incidence and etiology. Neurology (2004) 1.65
Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia (2002) 1.61
Adult brainstem gliomas. Neurology (1998) 1.61
Altered mental status in patients with cancer. Arch Neurol (2000) 1.60
111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology (1998) 1.59
Cognitive functions in survivors of primary central nervous system lymphoma. Neurology (2004) 1.59
Steroid myopathy in cancer patients. Neurology (1997) 1.57
Low-grade oligodendroglioma responds to chemotherapy. Neurology (1996) 1.56
Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet (1993) 1.54
Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther (2008) 1.49
Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology (1994) 1.46
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat (2001) 1.46
Increasing fruit and vegetable consumption through worksites and families in the treatwell 5-a-day study. Am J Public Health (1999) 1.43
Effectiveness of coping strategies among critical care nurses. Dimens Crit Care Nurs (1992) 1.43
'Natural' cancer prevention trial halted. Science (1996) 1.41
Finding the balance. Neuro Oncol (2001) 1.39
Brain contains two forms of synaptic vesicle protein 2. Proc Natl Acad Sci U S A (1993) 1.36
Cardiac amyloidosis, contrictive pericarditis and restrictive cardiomyopathy. Am J Cardiol (1976) 1.34
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res (1992) 1.31
Overuse injuries in triathletes. A study of the 1986 Seafair Triathlon. Am J Sports Med (1990) 1.31
The clinical spectrum of ocular lymphoma. Cancer (1993) 1.31
Immune dysregulation in the aging human lung. Am J Respir Crit Care Med (1996) 1.29
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci U S A (2000) 1.26
Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev (1998) 1.23
CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection. J Virol (2001) 1.22
Breast implants and breast cancer--reanalysis of a linkage study. N Engl J Med (1995) 1.20
Preschool children's eating behaviours are related to dietary adequacy and body weight. Eur J Clin Nutr (2006) 1.20
Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia. Neurology (1987) 1.17
Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. Ann Intern Med (1987) 1.17
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int J Clin Lab Res (1994) 1.16
Supratentorial ependymomas in adult patients. Neurosurgery (1999) 1.13
HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. Oncology (Williston Park) (1997) 1.12
Seasonal variation in weight-for-age in a pediatric emergency room. Public Health Rep (1996) 1.10
Motor neuropathy due to docetaxel and paclitaxel. Neurology (1996) 1.08
alpha-Amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. Blood (1994) 1.08
Male sex workers in three Australian cities: socio-demographic and sex work characteristics. J Homosex (2001) 1.08
Comparison of ultrasound and cineangiographic measurements of left ventricular performance in patients with and without wall motion abnormalities. Br Heart J (1973) 1.07
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer (1995) 1.06
Weighing the benefits and risks of radiation therapy for low-grade glioma. Neurology (2001) 1.06
The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology (1990) 1.05
Therapy of venous thromboembolism in patients with brain metastases. Cancer (1994) 1.03
Structure and chromosomal localization of the mammalian agrin gene. J Neurosci (1992) 1.03
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol (1993) 1.02
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study. Neuro Oncol (2001) 1.01
Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res (2001) 1.01
A double-blind, crossover trial of intravenous clodronate in metastatic bone pain. J Pain Symptom Manage (1992) 1.01
A clinical evaluation of 10 percent vs. 15 percent carbamide peroxide tooth-whitening agents. J Am Dent Assoc (2000) 1.00
Intention to have a mammogram in the future among women who have underused mammography in the past. Health Educ Behav (1998) 1.00
Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology (2010) 0.99
Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer. J Clin Oncol (1994) 0.99
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
Localization of the locus causing Spider Lamb Syndrome to the distal end of ovine Chromosome 6. Mamm Genome (1999) 0.98
Comparison of dietary assessment measures in the Treatwell 5 A Day worksite study. J Am Diet Assoc (1998) 0.98
Response of left ventricular volume to exercise in man assessed by radionuclide equilibrium angiography. Circulation (1979) 0.98
Binary transgenic mouse model for studying the trans control of globin gene switching: evidence that GATA-1 is an in vivo repressor of human epsilon gene expression. Proc Natl Acad Sci U S A (1997) 0.98
Intracranial tuberculoma: case report and review of the literature. Neurology (1981) 0.97
Primary central nervous system T-cell lymphoma. Neurology (2001) 0.96
Efficient activation of nucleoside phosphoramidites with 4,5-dicyanoimidazole during oligonucleotide synthesis. Nucleic Acids Res (1998) 0.96
Staged diabetes management. Toward an integrated model of diabetes care. Diabetes Care (1994) 0.95
Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids. Mol Cell Biol (1995) 0.95
Bevacizumab for recurrent ependymoma. Neurology (2009) 0.95
The spectrum of neurological disease in patients with systemic cancer. Ann Neurol (1992) 0.95
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol (1998) 0.94
Left ventricular volumes by gated equilibrium radionuclide angiography: a new method. Circulation (1979) 0.94
Chemotherapy for brain tumors. Oncology (Williston Park) (1998) 0.93
A profile of the clients of male sex workers in three Australian cities. Aust N Z J Public Health (1999) 0.93
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays. Ann Oncol (2011) 0.93
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Ann Oncol (2011) 0.92
Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol (1995) 0.92
5-methyl-5,6,7,8-tetrahydropteroyl oligo-gamma-L-glutamates: synthesis and kinetic studies with methionine synthetase from bovine brain. Biochemistry (1975) 0.90
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol (2011) 0.90
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clin Cancer Res (2001) 0.90